Wacker Biotech is your CDMO partner for the entire manufacturing chain of plasmid DNA (pDNA) to RNA to lipid nanoparticle (LNP) formulations. We also provide pDNA for lentiviral and AAV-delivered cell and gene therapies and for direct pDNA applications. From state-of-the-art facilities in Europe and the US, a global team of process development scientists, manufacturing experts and R&D scientists accelerate our partners’ programs from R&D to commercialization.